Promising drug cocktail aims to shrink penile cancer before surgery
Disease control
Not yet recruiting
This phase II trial tests a combination of two drugs—Becotatug vedotin (a targeted therapy that attacks cancer cells with a specific protein) and Pucotenlimab (an immunotherapy that boosts the immune system)—in men with advanced penile cancer that is hard to treat with surgery al…
Phase: PHASE2 • Sponsor: Jiyan Liu • Aim: Disease control
Last updated Jul 02, 2026 07:00 UTC